Clovis Oncology (CLVS) Misses Q4 EPS by 18c
Tweet
Share
E-mail
Get Alerts CLVS Hot Sheet
Join SI Premium – FREE
Clovis Oncology (NASDAQ: CLVS) reported Q4 EPS of ($1.83), $0.18 worse than the analyst estimate of ($1.65).
For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rexford Industrial Realty (REXR) Reports In-Line Q1 EPS, provides guidance
- First Industrial Realty (FR) Tops Q1 EPS by 21c
- Old Second Bancorp (OSBC) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
